Recent Quotes

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA. The company primarily operates in the United States, Canada, China and other parts of the world.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-09
REV		(EXPECTED)2021-08-09

Q1 2021		Est.		Actual		Surprise
EPS		-0.060		-0.110		-0.0500
REV		5.050M		5.736M		686.000K

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
CASI	CASI Pharmaceuticals	1.28	-0.04	-3.03%		178.9M

CASI Pharmaceuticals Frequently Asked Questions

How do I buy CASI Pharmaceuticals (CASI) stock?

You can purchase shares of CASI Pharmaceuticals (NASDAQ: CASI) through any online brokerage.

View our list of the best stock brokerages.

Who are CASI Pharmaceuticals's (CASI) competitors?

Other companies in CASI Pharmaceuticals’s space includes: AVEO Pharmaceuticals (NASDAQ:AVEO), Heat Biologics (NASDAQ:HTBX), Larimar Therapeutics (NASDAQ:LRMR), PhaseBio Pharmaceuticals (NASDAQ:PHAS) and Genfit (NASDAQ:GNFT).

What is the target price for CASI Pharmaceuticals (CASI) stock?

The latest price target for CASI Pharmaceuticals (NASDAQ: CASI) was reported by BTIG on May 18, 2021. The analyst firm set a price target for 4.00 expecting CASI to rise to within 12 months (a possible 212.50% upside). 4 analyst firms have reported ratings in the last year.

Current Stock Price for CASI Pharmaceuticals (CASI)?

The stock price for CASI Pharmaceuticals (NASDAQ: CASI) is $1.28 last updated Fri Jul 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Does CASI Pharmaceuticals (CASI) pay a dividend?

There are no upcoming dividends for CASI Pharmaceuticals.

When is CASI Pharmaceuticals (NASDAQ:CASI) reporting earnings?

CASI Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 9, 2021.

Is CASI Pharmaceuticals (CASI) going to split?

There is no upcoming split for CASI Pharmaceuticals.

What sector and industry does CASI Pharmaceuticals (CASI) operate in?

CASI Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.